Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00005847
What this trial is testing

Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00284752
What this trial is testing

Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Kaiser Permanente 56
Not applicableActive Not RecruitingNCT07352748
What this trial is testing

Exploiting Heterogeneity in Hormone Therapy Response to Reveal Early Determinants of Drug Resistance in Advanced PCa

Who this might be right for
Metastatic Prostate Cancer
Universita di Verona 30
Testing effectiveness (Phase 2)UnknownNCT05461261
What this trial is testing

The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
Hormone Sensitive Metastatic Prostate CancerDNA Damage Repair DeficiencyChemotherapy Effect+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 50
Testing effectiveness (Phase 2)Study completedNCT01981122
What this trial is testing

Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Dendreon 52
Not applicableStudy completedNCT01233557
What this trial is testing

Biomarkers of Bone Resorption in Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
University of Aberdeen 40
Testing effectiveness (Phase 2)Study completedNCT01576029
What this trial is testing

Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Sanofi 2
Not applicableUnknownNCT01168141
What this trial is testing

Window Study of ZD4054 in Metastatic Prostate Cancer

Who this might be right for
Prostate CancerMetastasis
The Christie NHS Foundation Trust 30
Testing effectiveness (Phase 2)WithdrawnNCT01087580
What this trial is testing

Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer

Who this might be right for
PROSTATE CANCER
Northwestern University
Testing effectiveness (Phase 2)Ended earlyNCT00471718
What this trial is testing

ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
Vanderbilt-Ingram Cancer Center 27
Not applicableLooking for participantsNCT07370597
What this trial is testing

LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate Cancer Patients Treated With PSMA Radioligand THerapy.

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Jules Bordet Institute 110
Large-scale testing (Phase 3)Active Not RecruitingNCT02446405
What this trial is testing

Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasms
University of Sydney 1,125
Large-scale testing (Phase 3)Study completedNCT05458856
What this trial is testing

Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate

Who this might be right for
Prostate Cancer
Ipsen 147
Testing effectiveness (Phase 2)Study completedNCT00006023
What this trial is testing

Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Swiss Cancer Institute
Not applicableStudy completedNCT04000776
What this trial is testing

3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Université de Sherbrooke 100
Large-scale testing (Phase 3)Study completedNCT02294461
What this trial is testing

An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants

Who this might be right for
Progressive Metastatic Prostate Cancer
Astellas Pharma Inc 395
Testing effectiveness (Phase 2)Active Not RecruitingNCT04478279
What this trial is testing

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

Who this might be right for
GlioblastomaMelanoma Stage IVBreast Cancer+11 more
Sapience Therapeutics 125
Testing effectiveness (Phase 2)Study completedNCT01533246
What this trial is testing

Linsitinib in Treating Patients With Asymptomatic or Mildly Symptomatic Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT01012141
What this trial is testing

Docetaxel With a Phytochemical in Treating Patients With Hormone Independent Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Centre Jean Perrin 30
Testing effectiveness (Phase 2)Study completedNCT04335682
What this trial is testing

Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide

Who this might be right for
Metastatic Prostate CancerProstate Cancer MetastaticProstate Cancer+3 more
Alliance Foundation Trials, LLC. 111
Next Page